Table 5.
AUC value for Long-term Mortality |
|||
---|---|---|---|
Fixed effects | Random effects | I2 | |
L3 Level measurement | |||
PMA | 0.654(0.625–0.683) | 0.666(0.584–0.748) | 0.82 |
PMD | 0.661(0.632–0.690) | 0.674(0.576–0.772) | 0.86 |
PMA/height | 0.652(0.623–0.681) | 0.664(0.585–0.743) | 0.81 |
PMA/BSA | 0.652(0.623-–0.681) | 0.665(0.579–0.751) | 0.83 |
sLPMA | 0.663(0.634–0.692) | 0.677(0.576–0.778) | 0.87 |
pLPMA | 0.662(0.633–0.691) | 0.675(0.577–0.773) | 0.87 |
L4 level measurement | |||
PMA | 0.652(0.623–0.681) | 0.663(0.584–0.742) | 0.81 |
PMD | 0.667(0.638–0.695) | 0.678(0.582–0.775) | 0.86 |
PMA/height | 0.650(0.621–0.679) | 0.661(0.584–0.738) | 0.80 |
PMA/BSA | 0.648(0.619–0.677) | 0.660(0.578–0.743) | 0.82 |
sLPMA | 0.668(0.639–0.696) | 0.679(0.578–0.780) | 0.88 |
pLPMA | 0.667(0.638–0.696) | 0.679(0.578–0.780) | 0.88 |
Abbreviations: PMA: Psoas muscle area; PMD: Psoas muscle density; BSA: body-surface area; sLPMA: sum score of lean psoas muscle mass; pLPMA: product score of lean psoas.